Innovative therapy for Classic Galactosemia - tale of two HTS.
about
Chemical Structure-Biological Activity Models for Pharmacophores' 3D-InteractionsMolecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.Sweet and sour: an update on classic galactosemia.Galactose and its Metabolites Deteriorate Metaphase II Mouse Oocyte Quality and Subsequent Embryo Development by Disrupting the Spindle Structure.The unfolded protein response has a protective role in yeast models of classic galactosemia.Purple sweet potato colour--a potential therapy for galactosemia?Allelic variation, aneuploidy, and nongenetic mechanisms suppress a monogenic trait in yeast.Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.Understanding human glycosylation disorders: biochemistry leads the charge.Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.GALK inhibitors for classic galactosemia.Neurologic sequela in a patient with galactosemia potentially mediated by interleukin-11 dysfunction.Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities.Epigenetic and SP1-mediated regulation is involved in the repression of galactokinase 1 gene in the liver of neonatal piglets born to betaine-supplemented sows.
P2860
Q26741313-4E68E4D3-4219-434F-8AD0-15DE756F261EQ30668563-D57F9161-691C-48EE-87D5-5B5A6DB73656Q33563888-DBD27D2C-E191-4062-8F04-870B7040402FQ33669582-0DC8ED4D-7B57-4D5A-8F23-F0452E5F4D83Q34374165-0FFD00F5-15E6-48BA-A91F-277E097E5183Q34388138-D1043395-FF7B-4B05-8EC1-B04187441F02Q34864297-4570CD8F-68B5-4612-B38B-973A5C126AE2Q36486013-51675A2A-A15C-448C-BF36-C82AFF64F6BEQ36666135-81602BCF-B3DF-4322-BDE8-D51D2BE2B287Q37425947-E7A9C433-D812-4E41-A3CA-D11CE4A72538Q37734008-AEBCA06B-7FB4-400E-9268-E17680AE1E96Q38234643-97939D3A-8429-4990-919C-E11C28B52687Q44828719-D4180D04-BFE6-47B0-8164-3BCB4F04A70CQ47632492-E30BC259-6EF9-4B17-9376-E9D710FC54EEQ51725786-EF2DB873-65E1-4655-9787-3E08264572BB
P2860
Innovative therapy for Classic Galactosemia - tale of two HTS.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Innovative therapy for Classic Galactosemia - tale of two HTS.
@ast
Innovative therapy for Classic Galactosemia - tale of two HTS.
@en
Innovative therapy for Classic Galactosemia - tale of two HTS.
@nl
type
label
Innovative therapy for Classic Galactosemia - tale of two HTS.
@ast
Innovative therapy for Classic Galactosemia - tale of two HTS.
@en
Innovative therapy for Classic Galactosemia - tale of two HTS.
@nl
prefLabel
Innovative therapy for Classic Galactosemia - tale of two HTS.
@ast
Innovative therapy for Classic Galactosemia - tale of two HTS.
@en
Innovative therapy for Classic Galactosemia - tale of two HTS.
@nl
P2093
P2860
P1476
Innovative therapy for Classic Galactosemia - tale of two HTS.
@en
P2093
H Vankayalapati
K J Wierenga
S I Odejinmi
P2860
P356
10.1016/J.YMGME.2011.09.028
P577
2011-10-01T00:00:00Z